← Eichor
Condition: Advanced Thyroid Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Thyroid Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Phase 4 · 8 location(s) · Fudan University · NCT06195228XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Phase 2 · 2 location(s) · Jochen Lorch · NCT06959641APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2 · 35 location(s) · Apollomics Inc. · NCT03175224RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
Phase N/A · 1 location(s) · Fudan University · NCT06524167Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · ModeX Therapeutics, An OPKO Health Company · NCT06239194Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and
Phase 2 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT07016230HEC169096 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Sunshine Lake Pharma Co., Ltd. · NCT05451602Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Phase 2 · 1 location(s) · Beijing Scitech-Mq Pharmaceuticals Limited · NCT06359847A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · 165 location(s) · Turning Point Therapeutics, Inc. · NCT03093116Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
Phase N/A · 1 location(s) · Fujian Medical University · NCT07419932Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
NA · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07068542Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Phase 2 · 1 location(s) · West China Hospital · NCT06482086A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carc
Phase 3 · 35 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06860971A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NA · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT06405217CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07181720Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Phase 4 · 2 location(s) · Rigel Pharmaceuticals · NCT07704658Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer
Phase 2 · 1 location(s) · Fudan University · NCT05989425Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Phase 4 · 19 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT05830500Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 9 location(s) · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283Sacituzumab govitEcan in THYroid Cancers
Phase 2 · 11 location(s) · Grupo Espanol de Tumores Neuroendocrinos · NCT06235216Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Regis
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06507878Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06141369Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Adv
NA · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT06431620Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
Phase 2 · 1 location(s) · Yu Wang · NCT06787911A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced So
Phase 1 · 83 location(s) · Pfizer · NCT05538130Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Diff
Phase N/A · 3 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT05994365Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06863805MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
Phase 2 · 1 location(s) · Fudan University · NCT07235566
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.